摘要
Acute-on-chronic liver failure(ACLF) is increasingly recognized as a complex syndrome that is reversiblein many cases. It is characterized by an acute deterioration of liver function in the background of a pre-existing chronic liver disease often associated with a high short-term mortality rate. Organ failure(OF) is always associated, and plays a key role in determining the course, and the outcome of the disease. The definition of ACLF remains controversial due to its overall ambiguity, with several disparate criteria among various associations dedicated to the study of liver diseases. Although the precise pathogenesis needs to be clarified, it appears that an altered host response to injury might be a contributing factor caused by immune dysfunction, ultimately leading to a pro-inflammatory status, and eventually to OF. The PIRO concept(Predisposition, Insult, Response and Organ Failure) has been proposed to better approach the underlying mechanisms. It is accepted that ACLF is a different and specific form of liver failure, where a precipitating event is always involved, even though it cannot always be ascertained. According to several studies, infections and active alcoholism often trigger ACLF. Viral hepatitis, gastrointestinal haemorrhage, or drug induced liver injury, which can also provoke the syndrome. This review mainly focuses on the physiopathology and prognostic aspects. We believe these features are essential to further understanding and providing the rationale for improveddisease management strategies.
Acute-on-chronic liver failure(ACLF) is increasingly recognized as a complex syndrome that is reversiblein many cases. It is characterized by an acute deterioration of liver function in the background of a pre-existing chronic liver disease often associated with a high short-term mortality rate. Organ failure(OF) is always associated, and plays a key role in determining the course, and the outcome of the disease. The definition of ACLF remains controversial due to its overall ambiguity, with several disparate criteria among various associations dedicated to the study of liver diseases. Although the precise pathogenesis needs to be clarified, it appears that an altered host response to injury might be a contributing factor caused by immune dysfunction, ultimately leading to a pro-inflammatory status, and eventually to OF. The PIRO concept(Predisposition, Insult, Response and Organ Failure) has been proposed to better approach the underlying mechanisms. It is accepted that ACLF is a different and specific form of liver failure, where a precipitating event is always involved, even though it cannot always be ascertained. According to several studies, infections and active alcoholism often trigger ACLF. Viral hepatitis, gastrointestinal haemorrhage, or drug induced liver injury, which can also provoke the syndrome. This review mainly focuses on the physiopathology and prognostic aspects. We believe these features are essential to further understanding and providing the rationale for improveddisease management strategies.
引文
1 Lee WM,Stravitz RT,Larson AM.Introduction to the revised American Association for the Study of Liver Diseases Position Paper on acute liver failure 2011.Hepatology 2012;55:965-967[PMID:22213561 DOI:10.1002/hep.25551]
2 Lee WM.Etiologies of acute liver failure.Semin Liver Dis 2008;28:142-152[PMID:18452114 DOI:10.1055/s-2008-1073114]
3 Lee WM.Acute liver failure.N Engl J Med 1993;329:1862-1872[PMID:8305063 DOI:10.1056/NEJM199312163292508]
4 Moore KP,Wong F,Gines P,Bernardi M,Ochs A,Salerno F,Angeli P,Porayko M,Moreau R,Garcia-Tsao G,Jimenez W,Planas R,Arroyo V.The management of ascites in cirrhosis:report on the consensus conference of the International Ascites Club.Hepatology 2003;38:258-266[PMID:12830009 DOI:10.1053/jhep.2003.50315]
5 Ohnishi H,Sugihara J,Moriwaki H,Muto Y.[Acute-on-chronic liver failure].Ryoikibetsu Shokogun Shirizu 1995;(7):217-219[PMID:8749457]
6 Jalan R,Gines P,Olson JC,Mookerjee RP,Moreau R,GarciaTsao G,Arroyo V,Kamath PS.Acute-on chronic liver failure.J Hepatol 2012;57:1336-1348[PMID:22750750 DOI:10.1016/j.jhep.2012.06.026]
7 Jalan R,Yurdaydin C,Bajaj JS,Acharya SK,Arroyo V,Lin HC,Gines P,Kim WR,Kamath PS.Toward an improved definition of acute-on-chronic liver failure.Gastroenterology 2014;147:4-10[PMID:24853409 DOI:10.1053/j.gastro.2014.05.005]
8 Wlodzimirow K,Abu-Hanna A,Chamuleau RA.Acute-on-chronic liver failure-its definition remains unclear.J Hepatol 2013;59:190-191[PMID:23462694 DOI:10.1016/j.jhep.2013.02.011]
9 Bajaj JS.Defining acute-on-chronic liver failure:will East and West ever meet?Gastroenterology 2013;144:1337-1339[PMID:23623966 DOI:10.1053/j.gastro.2013.04.024]
10 Sarin SK,Kumar A,Almeida JA,Chawla YK,Fan ST,Garg H,de Silva HJ,Hamid SS,Jalan R,Komolmit P,Lau GK,Liu Q,Madan K,Mohamed R,Ning Q,Rahman S,Rastogi A,Riordan SM,Sakhuja P,Samuel D,Shah S,Sharma BC,Sharma P,Takikawa Y,Thapa BR,Wai CT,Yuen MF.Acute-on-chronic liver failure:consensus recommendations of the Asian Pacific Association for the study of the liver(APASL).Hepatol Int 2009;3:269-282[PMID:19669378 DOI:10.1007/s12072-008-9106-x]
11 Olson JC,Kamath PS.Acute-on-chronic liver failure:concept,natural history,and prognosis.Curr Opin Crit Care 2011;17:165-169[PMID:21326095 DOI:10.1097/MCC.0b013e328344b42d]
12 Moreau R,Jalan R,Gines P,Pavesi M,Angeli P,Cordoba J,Durand F,Gustot T,Saliba F,Domenicali M,Gerbes A,Wendon J,Alessandria C,Laleman W,Zeuzem S,Trebicka J,Bernardi M,Arroyo V;CANONIC Study Investigators of the EASL-CLIF Consortium.Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis.Gastroenterology 2013;144:1426-1437,1437.e1-9[PMID:23474284 DOI:10.1053/j.gastro.2013.02.042]
13 B l e i D A,Cordoba J.[Hepatic encephalopathy].R o m J Gastroenterol 2002;11:163-165[PMID:12240601]
14 Arvaniti V,D’Amico G,Fede G,Manousou P,Tsochatzis E,Pleguezuelo M,Burroughs AK.Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis.Gastroenterology 2010;139:1246-1256,1256.e1-5[PMID:20558165 DOI:10.1053/j.gastro.2010.06.019]
15 Herrera JL.Management of acute variceal bleeding.Clin Liver Dis 2014;18:347-357[PMID:24679499 DOI:10.1016/j.cld.2014.01.001]
16 Tripathi D,Stanley AJ,Hayes PC,Patch D,Millson C,Mehrzad H,Austin A,Ferguson JW,Olliff SP,Hudson M,Christie JM.UK guidelines on the management of variceal haemorrhage in cirrhotic patients.Gut 2015;64:1680-1704[PMID:25887380]
17 Vincent JL,Moreno R,Takala J,Willatts S,De Mendon?a A,Bruining H,Reinhart CK,Suter PM,Thijs LG.The SOFA(Sepsis-related Organ Failure Assessment)score to describe organ dysfunction/failure.On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine.Intensive Care Med 1996;22:707-710[PMID:8844239]
18 Silva PE,Fayad L,Lazzarotto C,Ronsoni MF,Bazzo ML,Colombo BS,Dantas-Correa EB,Narciso-Schiavon JL,Schiavon LL.Single-centre validation of the EASL-CLIF consortium definition of acute-on-chronic liver failure and CLIF-SOFA for prediction of mortality in cirrhosis.Liver Int 2015;35:1516-1523[PMID:24840673 DOI:10.1111/liv.12597]
19 Dhiman RK,Agrawal S,Gupta T,Duseja A,Chawla Y.Chronic Liver Failure-Sequential Organ Failure Assessment is better than the Asia-Pacific Association for the Study of Liver criteria for defining acute-on-chronic liver failure and predicting outcome.World J Gastroenterol 2014;20:14934-14941[PMID:25356054DOI:10.3748/wjg.v20.i40.14934]
20 Dupont B,Delvincourt M,KonéM,du Cheyron D,OllivierHourmand I,Piquet MA,Terzi N,Dao T.Retrospective evaluation of prognostic score performances in cirrhotic patients admitted to an intermediate care unit.Dig Liver Dis 2015;47:675-681[PMID:25937626]
21 Mc Phail MJ,Shawcross DL,Abeles RD,Chang A,Patel V,Lee GH,Abdulla M,Sizer E,Willars C,Auzinger G,Bernal W,Wendon JA.Increased Survival for Patients With Cirrhosis and Organ Failure in Liver Intensive Care and Validation of the Chronic Liver Failure-Sequential Organ Failure Scoring System.Clin Gastroenterol Hepatol 2015;13:1353-1360.e8[PMID:25240417]
22 Marshall J,Sweeney D.Microbial infection and the septic response in critical surgical illness.Sepsis,not infection,determines outcome.Arch Surg 1990;125:17-22;discussion 22-23[PMID:2294878]
23 Levy MM,Fink MP,Marshall JC,Abraham E,Angus D,Cook D,Cohen J,Opal SM,Vincent JL,Ramsay G.2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.Intensive Care Med 2003;29:530-538[PMID:12664219 DOI:10 .1007/s00134-003-1662-x]
24 Chen YX,Li CS.Risk stratification and prognostic performance of the predisposition,infection,response,and organ dysfunction(PIRO)scoring system in septic patients in the emergency department:a cohort study.Crit Care 2014;18:R74[PMID:24739219 DOI:10.1186/cc13832]
25 Kim TY,Kim DJ.Acute-on-chronic liver failure.Clin Mol Hepatol 2013;19:349-359[PMID:24459638 DOI:10.3350/cmh.2013.19.4.349]
26 Lee WM,Squires RH,Nyberg SL,Doo E,Hoofnagle JH.Acute liver failure:Summary of a workshop.Hepatology 2008;47:1401-1415[PMID:18318440 DOI:10.1002/hep.22177]
27 Kumar A,Saraswat VA.Hepatitis E and Acute-on-Chronic Liver Failure.J Clin Exp Hepatol 2013;3:225-230[PMID:25755504DOI:10.1016/j.jceh.2013.08.013]
28 Kumar Acharya S,Kumar Sharma P,Singh R,Kumar Mohanty S,Madan K,Kumar Jha J,Kumar Panda S.Hepatitis E virus(HEV)infection in patients with cirrhosis is associated with rapid decompensation and death.J Hepatol 2007;46:387-394[PMID:17125878]
29 Rolando N,Wade J,Davalos M,Wendon J,Philpott-Howard J,WilliamsR.The systemic inflammatory response syndrome in acute liver failure.Hepatology 2000;32:734-739[PMID:11003617]
30 Wasmuth HE,Kunz D,Yagmur E,Timmer-Strangh?ner A,Vidacek D,Siewert E,Bach J,Geier A,Purucker EA,Gressner AM,Matern S,Lammert F.Patients with acute on chronic liver failure display“sepsis-like”immune paralysis.J Hepatol 2005;42:195-201[PMID:15664244]
31 Mookerjee RP,Stadlbauer V,Lidder S,Wright GA,Hodges SJ,Davies NA,Jalan R.Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts the outcome.Hepatology 2007;46:831-840[PMID:17680644 DOI:10.1002/hep.21737]
32 Ambrosino G,Naso A,Feltracco P,Carraro P,Basso SM,Varotto S,Cillo U,Zanus G,Boccagni P,Brolese A,Plebani M,Giron G,D’Amico DF.Cytokines and liver failure:modification of TNFand IL-6 in patients with acute on chronic liver decompensation treated with Molecular Adsorbent Recycling System(MARS).Acta Biomed 2003;74 Suppl 2:7-9[PMID:15055025]
33 Verbeke L,Nevens F,Laleman W.Bench-to-beside review:acute-on-chronic liver failure-linking the gut,liver and systemic circulation.Crit Care 2011;15:233[PMID:22104633 DOI:10 .1186/cc10424]
34 Steib CJ,Bilzer M,H?rtl JM,Beitinger F,Gülberg V,G?ke B,Gerbes AL.Kupffer cell activation by hydrogen peroxide:a new mechanism of portal pressure increase.Shock 2010;33:412-418[PMID:20118678 DOI:10.1097/SHK.0b013e3181b85934]
35 Bilzer M,Roggel F,Gerbes AL.Role of Kupffer cells in host defense and liver disease.Liver Int 2006;26:1175-1186[PMID:17105582]
36 Holland-Fischer P,Gr?nb?k H,Sandahl TD,Moestrup SK,Riggio O,Ridola L,Aagaard NK,M?ller HJ,Vilstrup H.Kupffer cells are activated in cirrhotic portal hypertension and not normalised by TIPS.Gut 2011;60:1389-1393[PMID:21572121DOI:10.1136/gut.2010.234542]
37 Rockey DC,Fouassier L,Chung JJ,Carayon A,Vallee P,Rey C,Housset C.Cellular localization of endothelin-1 and increased production in liver injury in the rat:potential for autocrine and paracrine effects on stellate cells.Hepatology 1998;27:472-480[PMID:9462646]
38 Adebayo D,Morabito V,Andreola F,Pieri G,Luong TV,Dhillon A,Mookerjee R,Jalan R.Mechanism of cell death in acute-onchronic liver failure:a clinico-pathologic-biomarker study.Liver Int 2015;Epub ahead of print[PMID:25879577 DOI:10.1111/liv.12850]
39 Brann OS.Infectious complications of cirrhosis.Curr Gastroenterol Rep 2001;3:285-292[PMID:11469997]
40 Sipeki N,Antal-Szalmas P,Lakatos PL,Papp M.Immune dysfunction in cirrhosis.World J Gastroenterol 2014;20:2564-2577[PMID:24627592 DOI:10.3748/wjg.v20.i10.2564]
41 Racanelli V,Rehermann B.The liver as an immunological organ.Hepatology 2006;43:S54-S62[PMID:16447271 DOI:10.1002/hep.21060]
42 Jenne CN,Kubes P.Immune surveillance by the liver.Nat Immunol 2013;14:996-1006[PMID:24048121 DOI:10.1038/ni.2691]
43 Runyon BA,Morrissey RL,Hoefs JC,Wyle FA.Opsonic activity of human ascitic fluid:a potentially important protective mechanism against spontaneous bacterial peritonitis.Hepatology1985;5:634-637[PMID:4018735]
44 Albillos A,Lario M,álvarez-Mon M.Cirrhosis-associated immune dysfunction:distinctive features and clinical relevance.J Hepatol 2014;61:1385-1396[PMID:25135860 DOI:10.1016/j.jhep.2014.08.010]
45 Arroyo V,Moreau R,Jalan R,Ginès P.Acute-on-chronic liver failure:A new syndrome that will re-classify cirrhosis.J Hepatol2015;62:S131-S143[PMID:25920082]
46 Leber B,Spindelboeck W,Stadlbauer V.Infectious complications of acute and chronic liver disease.Semin Respir Crit Care Med2012;33:80-95[PMID:22447263 DOI:10.1055/s-0032-1301737]
47 R a j k o v i c I A,Williams R.Abnormalities of neutrophil phagocytosis,intracellular killing and metabolic activity in alcoholic cirrhosis and hepatitis.Hepatology 1986;6:252-262[PMID:3007318]
48 Rimola A,Soto R,Bory F,Arroyo V,Piera C,Rodes J.Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis.Hepatology 1984;4:53-58[PMID:6693068]
49 Fernández J,Gustot T.Management of bacterial infections in cirrhosis.J Hepatol 2012;56 Suppl 1:S1-12[PMID:22300459DOI:10.1016/S0168-8278(12)60002-6]
50 Borzio M,Salerno F,Piantoni L,Cazzaniga M,Angeli P,Bissoli F,Boccia S,Colloredo-Mels G,Corigliano P,Fornaciari G,Marenco G,PistaràR,Salvagnini M,Sangiovanni A.Bacterial infection in patients with advanced cirrhosis:a multicentre prospective study.Dig Liver Dis 2001;33:41-48[PMID:11303974]
51 Navasa M,Fernández J,Rodés J.Bacterial infections in liver cirrhosis.Ital J Gastroenterol Hepatol 1999;31:616-625[PMID:10604106]
52 Yang YY,Lin HC.Bacterial infections in patients with cirrhosis.J Chin Med Assoc 2005;68:447-451[PMID:16265857]
53 Tandon P,Garcia-Tsao G.Bacterial infections,sepsis,and multiorgan failure in cirrhosis.Semin Liver Dis 2008;28:26-42[PMID:18293275 DOI:10.1055/s-2008-1040319]
54 Fernández J,Navasa M,Gómez J,Colmenero J,Vila J,Arroyo V,Rodés J.Bacterial infections in cirrhosis:epidemiological changes with invasive procedures and norfloxacin prophylaxis.Hepatology2002;35:140-148[PMID:11786970]
55 Caly WR,Strauss E.A prospective study of bacterial infections in patients with cirrhosis.J Hepatol 1993;18:353-358[PMID:8228129]
56 Anastasiadis SN,Giouleme OI,Germanidis GS,Vasiliadis TG.Relative adrenal insufficiency in cirrhotic patients.Clin Med Insights Gastroenterol 2015;8:13-17[PMID:25780347 DOI:10 .4137/CGast.S18127]
57 Fernández J,Escorsell A,Zabalza M,Felipe V,Navasa M,Mas A,Lacy AM,Ginès P,Arroyo V.Adrenal insufficiency in patients with cirrhosis and septic shock:Effect of treatment with hydrocortisone on survival.Hepatology 2006;44:1288-1295[PMID:17058239DOI:10.1002/hep.21352]
58 Tsai MH,Peng YS,Chen YC,Liu NJ,Ho YP,Fang JT,Lien JM,Yang C,Chen PC,Wu CS.Adrenal insufficiency in patients with cirrhosis,severe sepsis and septic shock.Hepatology 2006;43:673-681[PMID:16557538 DOI:10.1002/hep.21101]
59 Karagiannis AK,Nakouti T,Pipili C,Cholongitas E.Adrenal insufficiency in patients with decompensated cirrhosis.World J Hepatol 2015;7:1112-1124[PMID:26052400 DOI:10.4254/wjh.v7.i8.1112]
60 Trifan A,Chiriac S,Stanciu C.Update on adrenal insufficiency in patients with liver cirrhosis.World J Gastroenterol 2013;19:445-456[PMID:23382623 DOI:10.3748/wjg.v19.i4.445]
61 Arabi YM,Aljumah A,Dabbagh O,Tamim HM,Rishu AH,AlAbdulkareem A,Knawy BA,Hajeer AH,Tamimi W,Cherfan A.Low-dose hydrocortisone in patients with cirrhosis and septic shock:a randomized controlled trial.CMAJ 2010;182:1971-1977[PMID:21059778 DOI:10.1503/cmaj.090707]
62 Fede G,Spadaro L,Tomaselli T,Privitera G,Germani G,Tsochatzis E,Thomas M,Bouloux PM,Burroughs AK,Purrello F.Adrenocortical dysfunction in liver disease:a systematic review.Hepatology 2012;55:1282-1291[PMID:22234976 DOI:10.1002/hep.25573]
63 Vlaar AP,Juffermans NP.Transfusion-related acute lung injury:a clinical review.Lancet 2013;382:984-994[PMID:23642914DOI:10.1016/S0140-6736(12)62197-7]
64 Vlaar AP.Transfusion-related acute lung injury:Current understanding and preventive strategies.Transfus Clin Biol 2012;19:117-124[PMID:22682310 DOI:10.1016/j.tracli.2012.03.001]
65 Christou L,Pappas G,Falagas ME.Bacterial infection-related morbidity and mortality in cirrhosis.Am J Gastroenterol 2007;102:1510-1517[PMID:17509025]
66 Sargenti K,Prytz H,Nilsson E,Bertilsson S,Kalaitzakis E.Bacterial infections in alcoholic and nonalcoholic liver cirrhosis.Eur J Gastroenterol Hepatol 2015;27:1080-1086[PMID:26011234 DOI:10.1097/MEG.0000000000000396]
67 O’Leary JG,Reddy KR,Wong F,Kamath PS,Patton HM,Biggins SW,Fallon MB,Garcia-Tsao G,Subramanian RM,Malik R,Thacker LR,Bajaj JS.Long-term use of antibiotics and proton pump inhibitors predict development of infections in patients with cirrhosis.Clin Gastroenterol Hepatol 2015;13:753-9.e1-753-9.e2[PMID:25130937 DOI:10.1016/j.cgh.2014.07.060]
68 Bajaj JS,O’Leary JG,Reddy KR,Wong F,Olson JC,Subramanian RM,Brown G,Noble NA,Thacker LR,Kamath PS.Second infections independently increase mortality in hospitalized patients with cirrhosis:the North American consortium for the study of end-stage liver disease(NACSELD)experience.Hepatology 2012;56:2328-2335[PMID:22806618 DOI:10.1002/hep.25947]
69 Bajaj JS,O’Leary JG,Reddy KR,Wong F,Biggins SW,Patton H,Fallon MB,Garcia-Tsao G,Maliakkal B,Malik R,Subramanian RM,Thacker LR,Kamath PS.Survival in infection-related acuteon-chronic liver failure is defined by extrahepatic organ failures.Hepatology 2014;60:250-256[PMID:24677131 DOI:10.1002/hep.27077]
70 Mackavey CL,Hanks R.Hemostasis,coagulation abnormalities,and liver disease.Crit Care Nurs Clin North Am 2013;25:435-46,v[PMID:24267280 DOI:10.1016/j.ccell.2013.09.001]
71 Caldwell SH,Hoffman M,Lisman T,Macik BG,Northup PG,Reddy KR,Tripodi A,Sanyal AJ.Coagulation disorders and hemostasis in liver disease:pathophysiology and critical assessment of current management.Hepatology 2006;44:1039-1046[PMID:17006940 DOI:10.1002/hep.21303]
72 Mannucci PM,Tripodi A.Liver disease,coagulopathies and transfusion therapy.Blood Transfus 2013;11:32-36[PMID:23058863 DOI:10.2450/2012.0151-12]
73 Tripodi A,Primignani M,Lemma L,Chantarangkul V,Mannucci PM.Evidence that low protein C contributes to the procoagulant imbalance in cirrhosis.J Hepatol 2013;59:265-270[PMID:23583273 DOI:10.1016/j.jhep.2013.03.036]
74 Tripodi A,Mannucci PM.The coagulopathy of chronic liver disease.N Engl J Med 2011;365:147-156[PMID:21751907 DOI:10 .1056/NEJMra1011170]
75 Tripodi A,Anstee QM,Sogaard KK,Primignani M,Valla DC.Hypercoagulability in cirrhosis:causes and consequences.J Thromb Haemost 2011;9:1713-1723[PMID:21729237 DOI:10 .1111/j.1538-7836.2011.04429.x]
76 Mannucci PM,Tripodi A.Hemostatic defects in liver and renal dysfunction.Hematology Am Soc Hematol Educ Program 2012;2012:168-173[PMID:23233577 DOI:10.1182/asheducation-2012.1.168]
77 Lisman T,Stravitz RT.Rebalanced Hemostasis in Patients with Acute Liver Failure.Semin Thromb Hemost 2015;41:468-473[PMID:26049071 DOI:10.1055/s-0035-1550430]
78 Lisman T,Porte RJ.Platelet function in patients with cirrhosis.J Hepatol 2012;56:993-994;author reply 994-995[PMID:22424439 DOI:10.1016/j.jhep.2011.08.013]
79 Kalambokis GN,Mouzaki A,Rodi M,Pappas K,Fotopoulos A,Xourgia X,Tsianos EV.Rifaximin improves systemic hemodynamics and renal function in patients with alcohol-related cirrhosis and ascites.Clin Gastroenterol Hepatol 2012;10:815-818[PMID:22391344 DOI:10.1016/j.cgh.2012.02.025]
80 Vlachogiannakos J,Saveriadis AS,Viazis N,Theodoropoulos I,Foudoulis K,Manolakopoulos S,Raptis S,Karamanolis DG.Intestinal decontamination improves liver haemodynamics in patients with alcohol-related decompensated cirrhosis.Aliment Pharmacol Ther 2009;29:992-999[PMID:19210289 DOI:10 .1111/j.1365-2036.2009.03958.x]
81 Schaden E,Saner FH,Goerlinger K.Coagulation pattern in critical liver dysfunction.Curr Opin Crit Care 2013;19:142-148[PMID:23400090 DOI:10.1097/MCC.0b013e32835ebb52]
82 Northup PG,Caldwell SH.Coagulation in liver disease:a guide for the clinician.Clin Gastroenterol Hepatol 2013;11:1064-1074[PMID:23506859 DOI:10.1016/j.cgh.2013.02.026]
83 Lee GH.Hepatic encephalopathy in acute-on-chronic liver failure.Hepatol Int 2015;9:520-526[PMID:26016460 DOI:10.1007/s12072-015-9626-0]
84 J a l a n R,Williams R.Acute-on-chronic liver failure:pathophysiological basis of therapeutic options.Blood Purif 2002;20:252-261[PMID:11867872]
85 Atluri DK,Prakash R,Mullen KD.Pathogenesis,diagnosis,and treatment of hepatic encephalopathy.J Clin Exp Hepatol 2011;1:77-86[PMID:25755319 DOI:10.1016/S0973-6883(11)60126-6]
86 H?ussinger D,Schliess F.Pathogenetic mechanisms of hepatic encephalopathy.Gut 2008;57:1156-1165[PMID:18628377 DOI:10 .1136/gut.2007.122176]
87 Aldridge DR,Tranah EJ,Shawcross DL.Pathogenesis of hepatic encephalopathy:role of ammonia and systemic inflammation.J Clin Exp Hepatol 2015;5:S7-S20[PMID:26041962 DOI:10 .1016/j.jceh.2014.06.004]
88 Jayakumar AR,Rama Rao KV,Norenberg MD.Neuroinflammation in hepatic encephalopathy:mechanistic aspects.J Clin Exp Hepatol 2015;5:S21-S28[PMID:26041953 DOI:10 .1016/j.jceh.2014.07.006]
89 Sen S,Williams R,Jalan R.The pathophysiological basis of acuteon-chronic liver failure.Liver 2002;22 Suppl 2:5-13[PMID:12220296]
90 Cordoba J,Ventura-Cots M,Simón-Talero M,Amorósà,Pavesi M,Vilstrup H,Angeli P,Domenicali M,Ginés P,Bernardi M,Arroyo V.Characteristics,risk factors,and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure(ACLF).J Hepatol 2014;60:275-281[PMID:24128414 DOI:10.1016/j.jhep.2013.10.004]
91 Córdoba J,García-Martinez R,Simón-Talero M.Hyponatremic and hepatic encephalopathies:similarities,differences and coexistence.Metab Brain Dis 2010;25:73-80[PMID:20217202DOI:10.1007/s11011-010-9172-3]
92 Shawcross DL,Sharifi Y,Canavan JB,Yeoman AD,Abeles RD,Taylor NJ,Auzinger G,Bernal W,Wendon JA.Infection and systemic inflammation,not ammonia,are associated with Grade 3/4 hepatic encephalopathy,but not mortality in cirrhosis.J Hepatol 2011;54:640-649[PMID:21163546 DOI:10.1016/j.jhep.2010.07.045]
93 Laleman W,Wilmer A,Evenepoel P,Elst IV,Zeegers M,Zaman Z,Verslype C,Fevery J,Nevens F.Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-onchronic alcoholic liver failure.Crit Care 2006;10:R108[PMID:16859530]
94 Schmidt LE,S?rensen VR,Svendsen LB,Hansen BA,Larsen FS.Hemodynamic changes during a single treatment with the molecular adsorbents recirculating system in patients with acuteon-chronic liver failure.Liver Transpl 2001;7:1034-1039[PMID:11753905]
95 Prin M,Bakker J,Wagener G.Hepatosplanchnic circulation in cirrhosis and sepsis.World J Gastroenterol 2015;21:2582-2592[PMID:25759525 DOI:10.3748/wjg.v21.i9.2582]
96 Theocharidou E,Krag A,Bendtsen F,M?ller S,Burroughs AK.Cardiac dysfunction in cirrhosis-does adrenal function play a role?A hypothesis.Liver Int 2012;32:1327-1332[PMID:22292920DOI:10.1111/j.1478-3231.2011.02751.x]
97 Liu H,Lee SS.Acute-on-chronic liver failure:the heart and systemic hemodynamics.Curr Opin Crit Care 2011;17:190-194[PMID:21326096 DOI:10.1097/MCC.0b013e328344b397]
98 Laleman W,Verbeke L,Meersseman P,Wauters J,van Pelt J,Cassiman D,Wilmer A,Verslype C,Nevens F.Acute-on-chronic liver failure:current concepts on definition,pathogenesis,clinical manifestations and potential therapeutic interventions.Expert Rev Gastroenterol Hepatol 2011;5:523-537;quiz 537[PMID:21780899 DOI:10.1586/egh.11.47]
99 Ruiz-del-Arbol L,Monescillo A,Arocena C,Valer P,Ginès P,Moreira V,Milicua JM,Jiménez W,Arroyo V.Circulatory function and hepatorenal syndrome in cirrhosis.Hepatology 2005;42:439-447[PMID:15977202 DOI:10.1002/hep.20766]
100 M?ller S,Hansen EF,Becker U,Brinch K,Henriksen JH,Bendtsen F.Central and systemic haemodynamic effects of terlipressin in portal hypertensive patients.Liver 2000;20:51-59[PMID:10726961]
101 Aggarwal A,Ong JP,Younossi ZM,Nelson DR,Hoffman-Hogg L,Arroliga AC.Predictors of mortality and resource utilization in cirrhotic patients admitted to the medical ICU.Chest 2001;119:1489-1497[PMID:11348958]
102 Fang JT,Tsai MH,Tian YC,Jenq CC,Lin CY,Chen YC,Lien JM,Chen PC,Yang CW.Outcome predictors and new score of critically ill cirrhotic patients with acute renal failure.Nephrol Dial Transplant 2008;23:1961-1969[PMID:18187499 DOI:10.1093/ndt/gfm914]
103 Karvellas CJ,Bagshaw SM.Advances in management and prognostication in critically ill cirrhotic patients.Curr Opin Crit Care 2014;20:210-217[PMID:24514101 DOI:10.1097/MCC.0000000000000067]
104 Zimmerman JE,Wagner DP,Seneff MG,Becker RB,Sun X,Knaus WA.Intensive care unit admissions with cirrhosis:riskstratifying patient groups and predicting individual survival.Hepatology 1996;23:1393-1401[PMID:8675156]
105 Cholongitas E,Senzolo M,Patch D,Kwong K,Nikolopoulou V,Leandro G,Shaw S,Burroughs AK.Risk factors,sequential organ failure assessment and model for end-stage liver disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit.Aliment Pharmacol Ther 2006;23:883-893[PMID:16573791]
106 Martín-LlahíM,Guevara M,Torre A,Fagundes C,Restuccia T,Gilabert R,SoláE,Pereira G,Marinelli M,Pavesi M,Fernández J,Rodés J,Arroyo V,Ginès P.Prognostic importance of the cause of renal failure in patients with cirrhosis.Gastroenterology 2011;140:488 -496.e4[PMID:20682324 DOI:10.1053/j.gastro.2010.07.043]
107 Olson JC,Wendon JA,Kramer DJ,Arroyo V,Jalan R,GarciaTsao G,Kamath PS.Intensive care of the patient with cirrhosis.Hepatology 2011;54:1864-1872[PMID:21898477 DOI:10.1002/hep.24622]
108 Thabut D,Massard J,Gangloff A,Carbonell N,Francoz C,Nguyen-Khac E,Duhamel C,Lebrec D,Poynard T,Moreau R.Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure.Hepatology 2007;46:1872-1882[PMID:17972337 DOI:10.1002/hep.21920]
109 Ginès P,Schrier RW.Renal failure in cirrhosis.N Engl J Med 2009;361:1279-1290[PMID:19776409 DOI:10.1056/NEJMra0809139]
110 Garcia-Tsao G,Parikh CR,Viola A.Acute kidney injury in cirrhosis.Hepatology 2008;48:2064-2077[PMID:19003880DOI:10.1002/hep.22605]
111 Angeli P,Gines P,Wong F,Bernardi M,Boyer TD,Gerbes A,Moreau R,Jalan R,Sarin SK,Piano S,Moore K,Lee SS,Durand F,Salerno F,Caraceni P,Kim WR,Arroyo V,Garcia-Tsao G.Diagnosis and management of acute kidney injury in patients with cirrhosis:revised consensus recommendations of the International Club of Ascites.Gut 2015;64:531-537[PMID:25631669 DOI:10 .1136/gutjnl-2014-308874]
112 Angeli P,Rodríguez E,Piano S,Ariza X,Morando F,SolàE,Romano A,García E,Pavesi M,Risso A,Gerbes A,Willars C,Bernardi M,Arroyo V,Ginès P.Acute kidney injury and acuteon-chronic liver failure classifications in prognosis assessment of patients with acute decompensation of cirrhosis.Gut 2015;64:1616-1622[PMID:25311034]
113 Stadlbauer V,Wright GA,Banaji M,Mukhopadhya A,Mookerjee RP,Moore K,Jalan R.Relationship between activation of the sympathetic nervous system and renal blood flow autoregulation in cirrhosis.Gastroenterology 2008;134:111-119[PMID:18166350DOI:10.1053/j.gastro.2007.10.055]
114 Nazar A,Pereira GH,Guevara M,Martín-Llahi M,Pepin MN,Marinelli M,SoláE,Baccaro ME,Terra C,Arroyo V,Ginès P.Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome.Hepatology 2010;51:219-226[PMID:19877168 DOI:10.1002/hep.23283]
115 Sort P,Navasa M,Arroyo V,Aldeguer X,Planas R,Ruiz-delArbol L,Castells L,Vargas V,Soriano G,Guevara M,Ginès P,Rodés J.Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.N Engl J Med 1999;341:403-409[PMID:10432325DOI:10.1056/NEJM199908053410603]
116 Ortega R,Ginès P,Uriz J,Cárdenas A,Calahorra B,De Las Heras D,Guevara M,Bataller R,Jiménez W,Arroyo V,Rodés J.Terlipressin therapy with and without albumin for patients with hepatorenal syndrome:results of a prospective,nonrandomized study.Hepatology 2002;36:941-948[PMID:12297842]
117 Akriviadis E,Botla R,Briggs W,Han S,Reynolds T,Shakil O.Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis:a double-blind,placebo-controlled trial.Gastroenterology 2000;119:1637-1648[PMID:11113085]
118 Cárdenas A,Ginès P.Acute-on-chronic liver failure:the kidneys.Curr Opin Crit Care 2011;17:184-189[PMID:21311322 DOI:10 .1097/MCC.0b013e328344b3da]
119 Triantos C,Samonakis D,Thalheimer U,Patch D,Burroughs A.The relationship between liver function and portal pressure:what comes first,the chicken or the egg?J Hepatol 2005;42:146-147;author reply 147-148[PMID:15629521]
120 Mookerjee RP.Acute-on-chronic liver failure:the liver and portal haemodynamics.Curr Opin Crit Care 2011;17:170-176[PMID:21346568 DOI:10.1097/MCC.0b013e328344a076]
121 Bauer M,Press AT,Trauner M.The liver in sepsis:patterns of response and injury.Curr Opin Crit Care 2013;19:123-127[PMID:23448974 DOI:10.1097/MCC.0b013e32835eba6d]
122 Mehta G,Mookerjee RP,Sharma V,Jalan R.Systemic inflammation is associated with increased intrahepatic resistance and mortality in alcohol-related acute-on-chronic liver failure.Liver Int 2015;35:724-734[PMID:24703488 DOI:10.1111/liv.12559]
123 Vallance P,Moncada S.Hyperdynamic circulation in cirrhosis:a role for nitric oxide?Lancet 1991;337:776-778[PMID:1706450]
124 Thabut D,Shah V.Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease:new targets for the treatment of portal hypertension?J Hepatol 2010;53:976-980[PMID:20800926 DOI:10.1016/j.jhep.2010.07.004]
125 Taura K,De Minicis S,Seki E,Hatano E,Iwaisako K,Osterreicher CH,Kodama Y,Miura K,Ikai I,Uemoto S,Brenner DA.Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis.Gastroenterology 2008;135:1729-1738[PMID:18823985 DOI:10.1053/j.gastro.2008.07.065]
126 Medina J,Arroyo AG,Sánchez-Madrid F,Moreno-Otero R.Angiogenesis in chronic inflammatory liver disease.Hepatology2004;39:1185-1195[PMID:15122744 DOI:10.1002/hep.20193]
127 Bosch J,Abraldes JG,Fernández M,García-Pagán JC.Hepatic endothelial dysfunction and abnormal angiogenesis:new targets in the treatment of portal hypertension.J Hepatol 2010;53:558-567[PMID:20561700 DOI:10.1016/j.jhep.2010.03.021]
128 Kumar A,Das K,Sharma P,Mehta V,Sharma BC,Sarin SK.Hemodynamic studies in acute-on-chronic liver failure.Dig Dis Sci 2009;54:869-878[PMID:18688717 DOI:10.1007/s10620-008-0421-9]
129 Jalan R,Mookerjee RP.Systemic hemodynamics,hepatic blood flow and portal pressure in patients with cirrhosis and multiorgan failure:The role of systemic inflammatory response and sympathetic activation[Abstract].Hepatology 2008;48(Suppl 1):1078A
130 Benten D,Wiest R.Gut microbiome and intestinal barrier failure--the“Achilles heel”in hepatology?J Hepatol 2012;56:1221-1223[PMID:22406521 DOI:10.1016/j.jhep.2012.03.003]
131 Chen Y,Guo J,Qian G,Fang D,Shi D,Guo L,Li L.Gut dysbiosis in acute-on-chronic liver failure and its predictive value for mortality.J Gastroenterol Hepatol 2015;30:1429-1437[PMID:25711972 DOI:10.1111/jgh.12932]
132 Jalan R,Stadlbauer V,Sen S,Cheshire L,Chang YM,Mookerjee RP.Role of predisposition,injury,response and organ failure in the prognosis of patients with acute-on-chronic liver failure:a prospective cohort study.Crit Care 2012;16:R227[PMID:23186071 DOI:10.1186/cc11882]
133 Jalan R,Mookerjee RP.Acute-on-chronic liver failure:an early biopsy is essential?Gut 2010;59:1455-1456[PMID:20947880DOI:10.1136/gut.2010.214627]
134 Rasaratnam B,Kaye D,Jennings G,Dudley F,Chin-Dusting J.The effect of selective intestinal decontamination on the hyperdynamic circulatory state in cirrhosis.A randomized trial.Ann Intern Med 2003;139:186-193[PMID:12899586]
135 Jalan R,Saliba F,Pavesi M,Amoros A,Moreau R,Ginès P,Levesque E,Durand F,Angeli P,Caraceni P,Hopf C,Alessandria C,Rodriguez E,Solis-Mu?oz P,Laleman W,Trebicka J,Zeuzem S,Gustot T,Mookerjee R,Elkrief L,Soriano G,Cordoba J,Morando F,Gerbes A,Agarwal B,Samuel D,Bernardi M,Arroyo V.Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure.J Hepatol 2014;61:1038-1047[PMID:24950482 DOI:10.1016/j.jhep.2014.06.012]
136 Zhang Q,Li Y,Han T,Nie C,Cai J,Liu H,Liu Y.Comparison of current diagnostic criteria for acute-on-chronic liver failure.PLo S One 2015;10:e0122158[PMID:25785855 DOI:10.1371/journal.pone.0122158]
137 Stravitz RT.Liver:Acute-on-chronic liver failure--no longer an entity without definition.Nat Rev Gastroenterol Hepatol 2014;11:580-581[PMID:25201039 DOI:10.1038/nrgastro.2014.161]
138 Wlodzimirow KA,Eslami S,Abu-Hanna A,Nieuwoudt M,Chamuleau RA.A systematic review on prognostic indicators of acute on chronic liver failure and their predictive value for mortality.Liver Int 2013;33:40-52[PMID:22429562 DOI:10 .1111/j.1478-3231.2012.02790.x]
139 Warrillow SJ.Predictions and outcomes for the critically ill patient with cirrhosis:is it time to settle on the SOFA and let jaundiced views on outcome MELD away?Crit Care Med 2010;38:2259-2260[PMID:20959755 DOI:10.1097/CCM.0b013e3181f84a23]
140 Das V,Boelle PY,Galbois A,Guidet B,Maury E,Carbonell N,Moreau R,Offenstadt G.Cirrhotic patients in the medical intensive care unit:early prognosis and long-term survival.Crit Care Med 2010;38:2108-2116[PMID:20802324 DOI:10.1097/CCM.0b013e3181f3dea9]
141 Karvellas CJ,Pink F,Mc Phail M,Austin M,Auzinger G,Bernal W,Sizer E,Kutsogiannis DJ,Eltringham I,Wendon JA.Bacteremia,acute physiology and chronic health evaluation II and modified end stage liver disease are independent predictors of mortality in critically ill nontransplanted patients with acute on chronic liver failure.Crit Care Med 2010;38:121-126[PMID:19770744 DOI:10.1097/CCM.0b013e3181b42a1c]
142 Wehler M,Kokoska J,Reulbach U,Hahn EG,Strauss R.Shortterm prognosis in critically ill patients with cirrhosis assessed by prognostic scoring systems.Hepatology 2001;34:255-261[PMID:11481609]
143 Stauber R,Stadlbauer V,Struber G,Kaufmann R.Evaluation of four prognostic scores in patients with acute-on-chronic liver failure.J Hepatol 2006;44(Suppl 2):S69-70
144 Amarapurkar D,Dharod MV,Chandnani M,Baijal R,Kumar P,Jain M,Patel N,Kamani P,Issar S,Shah N,Kulkarni S,Gautam S,Shah A,Doshi S.Acute-on-chronic liver failure:a prospective study to determine the clinical profile,outcome,and factors predicting mortality.Indian J Gastroenterol 2015;34:216-224[PMID:26080655 DOI:10.1007/s12664-015-0574-3]
145 Mikolasevic I,Milic S,Radic M,Orlic L,Bagic Z,Stimac D.Clinical profile,natural history,and predictors of mortality in patients with acute-on-chronic liver failure(ACLF).Wien Klin Wochenschr 2015;127:283-289[PMID:25821053 DOI:10.1007/s00508-015-0707-9]
146 Garg H,Kumar A,Garg V,Sharma P,Sharma BC,Sarin SK.Clinical profile and predictors of mortality in patients of acuteon-chronic liver failure.Dig Liver Dis 2012;44:166-171[PMID:21978580 DOI:10.1016/j.dld.2011.08.029]
147 Jalan R,Pavesi M,Saliba F,Amorós A,Fernandez J,HollandFischer P,Sawhney R,Mookerjee R,Caraceni P,Moreau R,Ginès P,Durand F,Angeli P,Alessandria C,Laleman W,Trebicka J,Samuel D,Zeuzem S,Gustot T,Gerbes AL,Wendon J,Bernardi M,Arroyo V.The CLIF Consortium Acute Decompensation score(CLIF-C ADs)for prognosis of hospitalised cirrhotic patients without acuteon-chronic liver failure.J Hepatol 2015;62:831-840[PMID:25463539 DOI:10.1016/j.jhep.2014.11.012]
148 Gustot T,Fernandez J,Garcia E,Morando F,Caraceni P,Alessandria C,Laleman W,Trebicka J,Elkrief L,Hopf C,SolísMunoz P,Saliba F,Zeuzem S,Albillos A,Benten D,MonteroAlvarez JL,Chivas MT,Concepción M,Córdoba J,Mc Cormick A,Stauber R,Vogel W,de Gottardi A,Welzel TM,Domenicali M,Risso A,Wendon J,Deulofeu C,Angeli P,Durand F,Pavesi M,Gerbes A,Jalan R,Moreau R,Ginés P,Bernardi M,Arroyo V.Clinical Course of acute-on-chronic liver failure syndrome and effects on prognosis.Hepatology 2015;62:243-252[PMID:25877702 DOI:10.1002/hep.27849]
149 Zheng YB,Huang ZL,Wu ZB,Zhang M,Gu YR,Su YJ,Lin CS,Zhu RH,Lin BL,Gao ZL.Dynamic changes of clinical features that predict the prognosis of acute-on-chronic hepatitis B liver failure:a retrospective cohort study.Int J Med Sci 2013;10:1658-1664[PMID:24151437 DOI:10.7150/ijms.6415]
150 Yi ZQ,Lu MH,Xu XW,Fu XY,Tan DM.A novel prognostic score for acute-on-chronic hepatitis B liver failure.J Huazhong Univ Sci Technolog Med Sci 2015;35:87-92[PMID:25673199DOI:10.1007/s11596-015-1394-5]
151 Kumar R,Krishnamoorthy TL,Tan HK,Lui HF,Chow WC.Change in model for end-stage liver disease score at two weeks,as an indicator of mortality or liver transplantation at 60 days in acute-on-chronic liver failure.Gastroenterol Rep(Oxf)2015;3:122-127[PMID:25391261 DOI:10.1093/gastro/gou075]
152 Moreau R,Jalan R,Arroyo V.Acute-on-Chronic Liver Failure:Recent Concepts.J Clin Exp Hepatol 2015;5:81-85[PMID:25941435 DOI:10.1016/j.jceh.2014.09.003]
153 Tsai MH,Peng YS,Lien JM,Weng HH,Ho YP,Yang C,Chu YY,Chen YC,Fang JT,Chiu CT,Chen PC.Multiple organ system failure in critically ill cirrhotic patients.A comparison of two multiple organ dysfunction/failure scoring systems.Digestion2004;69:190-200[PMID:15178929 DOI:10.1159/000078789]
154 Medzhitov R,Schneider DS,Soares MP.Disease tolerance as a defense strategy.Science 2012;335:936-941[PMID:22363001DOI:10.1126/science.1214935]
155 Shi Y,Zheng MH,Yang Y,Wei W,Yang Q,Hu A,Hu Y,Wu Y,Yan H.Increased delayed mortality in patients with acute-on-chronic liver failure who have prior decompensation.J Gastroenterol Hepatol 2015;30:712-718[PMID:25250673 DOI:10.1111/jgh.12787]
156 Bustamante J,Rimola A,Ventura PJ,Navasa M,Cirera I,Reggiardo V,Rodés J.Prognostic significance of hepatic encephalopathy in patients with cirrhosis.J Hepatol 1999;30:890-895[PMID:10365817]
157 Xia Q,Dai X,Zhang Y,Guo Y,Xu X,Yang Q,Du W,Liu X,Chen Y,Huang J,Li L.A modified MELD model for Chinese pre-ACLF and ACLF patients and it reveals poor prognosis in pre-ACLF patients.PLo S One 2013;8:e64379[PMID:23755119 DOI:10 .1371/journal.pone.0064379]
158 Yan H,Wu W,Yang Y,Wu Y,Yang Q,Shi Y.A novel integrated Model for End-Stage Liver Disease model predicts short-term prognosis of hepatitis B virus-related acute-on-chronic liver failure patients.Hepatol Res 2015;45:405-414[PMID:24849735 DOI:10 .1111/hepr.12362]
159 Shi Y,Yang Y,Hu Y,Wu W,Yang Q,Zheng M,Zhang S,Xu Z,Wu Y,Yan H,Chen Z.Acute-on-chronic liver failure precipitated by hepatic injury is distinct from that precipitated by extrahepatic insults.Hepatology 2015;62:232-242[PMID:25800029 DOI:10 .1002/hep.27795]
160 Wu SJ,Yan HD,Zheng ZX,Shi KQ,Wu FL,Xie YY,Fan YC,Ye BZ,Huang WJ,Chen YP,Zheng MH.Establishment and validation of ALPH-Q score to predict mortality risk in patients with acuteon-chronic hepatitis B liver failure:a prospective cohort study.Medicine(Baltimore)2015;94:e403[PMID:25590846 DOI:10 .1097/MD.0000000000000403]
161 Siddiqui MS,Stravitz RT.Intensive care unit management of patients with liver failure.Clin Liver Dis 2014;18:957-978[PMID:25438294 DOI:10.1016/j.cld.2014.07.012]
162 Zamora Nava LE,Aguirre Valadez J,Chávez-Tapia NC,Torre A.Acute-on-chronic liver failure:a review.Ther Clin Risk Manag2014;10:295-303[PMID:24790454 DOI:10.2147/TCRM.S59723]
163 Sargenti K,Prytz H,Strand A,Nilsson E,Kalaitzakis E.Healthcare-associated and nosocomial bacterial infections in cirrhosis:predictors and impact on outcome.Liver Int 2015;35:391-400[PMID:25039438 DOI:10.1111/liv.12625]
164 Bruns T,Zimmermann HW,Stallmach A.Risk factors and outcome of bacterial infections in cirrhosis.World J Gastroenterol2014;20:2542-2554[PMID:24627590 DOI:10.3748/wjg.v20.i10.2542]
165 Sen S,Davies NA,Mookerjee RP,Cheshire LM,Hodges SJ,Williams R,Jalan R.Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure:a randomized controlled study.Liver Transpl 2004;10:1109-1119[PMID:15350001 DOI:10 .1002/lt.20236]
166 Hassanein TI,Schade RR,Hepburn IS.Acute-on-chronic liver failure:extracorporeal liver assist devices.Curr Opin Crit Care 2011;17:195-203[PMID:21346566 DOI:10.1097/MCC.0b013e328344b3aa]
167 Kribben A,Gerken G,Haag S,Herget-Rosenthal S,Treichel U,Betz C,Sarrazin C,Hoste E,Van Vlierberghe H,Escorsell A,Hafer C,Schreiner O,Galle PR,Mancini E,Caraceni P,Karvellas CJ,Salmhofer H,Knotek M,Ginès P,Kozik-Jaromin J,Rifai K.Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure.Gastroenterology 2012;142:782-789.e3[PMID:22248661 DOI:10 .1053/j.gastro.2011.12.056]
168 Ba?ares R,Nevens F,Larsen FS,Jalan R,Albillos A,Dollinger M,Saliba F,Sauerbruch T,Klammt S,Ockenga J,Pares A,Wendon J,Brünnler T,Kramer L,Mathurin P,de la Mata M,Gasbarrini A,Müllhaupt B,Wilmer A,Laleman W,Eefsen M,Sen S,Zipprich A,Tenorio T,Pavesi M,Schmidt HH,Mitzner S,Williams R,Arroyo V.Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure:the RELIEF trial.Hepatology 2013;57:1153-1162[PMID:23213075 DOI:10 .1002/hep.26185]
169 Xu X,Liu X,Ling Q,Wei Q,Liu Z,Xu X,Zhou L,Zhang M,Wu J,Huang J,Sheng J,Zheng S,Li L.Artificial liver support system combined with liver transplantation in the treatment of patients with acute-on-chronic liver failure.PLo S One 2013;8:e58738[PMID:23516546 DOI:10.1371/journal.pone.0058738]
170 Ling Q,Xu X,Wei Q,Liu X,Guo H,Zhuang L,Chen J,Xia Q,Xie H,Wu J,Zheng S,Li L.Downgrading MELD improves the outcomes after liver transplantation in patients with acute-onchronic hepatitis B liver failure.PLo S One 2012;7:e30322[PMID:22291934 DOI:10.1371/journal.pone.0030322]
171 Stadlbauer V,Davies NA,Sen S,Jalan R.Artificial liver support systems in the management of complications of cirrhosis.Semin Liver Dis 2008;28:96-109[PMID:18293280 DOI:10.1055/s-2008-1040324]
172 Maiwall R,Maras JS,Nayak SL,Sarin SK.Liver dialysis in acuteon-chronic liver failure:current and future perspectives.Hepatol Int 2014;8 Suppl 2:505-513[PMID:26201332 DOI:10.1007/s12072-014-9534-8]
173 Khuroo MS,Khuroo MS,Farahat KL.Molecular adsorbent recirculating system for acute and acute-on-chronic liver failure:a meta-analysis.Liver Transpl 2004;10:1099-1106[PMID:15349999 DOI:10.1002/lt.20139]
174 Chan AC,Fan ST.Criteria for liver transplantation in ACLF and outcome.Hepatol Int 2015;9:355-359[PMID:25788183 DOI:10 .1007/s12072-014-9585-x]
175 Reddy MS,Rajalingam R,Rela M.Liver transplantation in acuteon-chronic liver failure:lessons learnt from acute liver failure setting.Hepatol Int 2015;9:508-513[PMID:25788191 DOI:10 .1007/s12072-014-9603-z]
176 Duseja A,Chawla YK,Dhiman RK,Kumar A,Choudhary N,Taneja S.Non-hepatic insults are common acute precipitants in patients with acute on chronic liver failure(ACLF).Dig Dis Sci 2010;55:3188-3192[PMID:20721624 DOI:10.1007/s10620-010-1377-0]
177 Katoonizadeh A,Laleman W,Verslype C,Wilmer A,Maleux G,Roskams T,Nevens F.Early features of acute-on-chronic alcoholic liver failure:a prospective cohort study.Gut 2010;59:1561-1569[PMID:20675694 DOI:10.1136/gut.2009.189639]
178 Finkenstedt A,Nachbaur K,Zoller H,Joannidis M,Pratschke J,Graziadei IW,Vogel W.Acute-on-chronic liver failure:excellent outcomes after liver transplantation but high mortality on the wait list.Liver Transpl 2013;19:879-886[PMID:23696006 DOI:10 .1002/lt.23678]
179 Liu CL,Fan ST,Lo CM,Wei WI,Yong BH,Lai CL,Wong J.Live-donor liver transplantation for acute-on-chronic hepatitis B liver failure.Transplantation 2003;76:1174-1179[PMID:14578749 DOI:10.1097/01.TP.0000087341.88471.E5]
180 Lin KH,Liu JW,Chen CL,Wang SH,Lin CC,Liu YW,Yong CC,Lin TL,Li WF,Hu TH,Wang CC.Impacts of pretransplant infections on clinical outcomes of patients with acute-on-chronic liver failure who received living-donor liver transplantation.PLo S One 2013;8:e72893[PMID:24023787 DOI:10.1371/journal.pone.0072893]
181 Chen Z,Wen T,Zeng Y,Wang L,Lu JJ,Gong S,Tan H,Feng P,Li B,Zhao J,Wang W,Xu M,Yang J,Wu H,Yan L.A single institution experience with living donor liver transplantation for acute-on-chronic hepatitis B liver failure.Hepatogastroenterology2011;58:1267-1273[PMID:21937395 DOI:10.5754/hge10148]
182 Chan AC,Fan ST,Lo CM,Liu CL,Chan SC,Ng KK,Yong BH,Chiu A,Lam BK.Liver transplantation for acute-on-chronic liver failure.Hepatol Int 2009;3:571-581[PMID:19680733 DOI:10 .1007/s12072-009-9148-8]
183 Bahirwani R,Shaked O,Bewtra M,Forde K,Reddy KR.Acuteon-chronic liver failure before liver transplantation:impact on posttransplant outcomes.Transplantation 2011;92:952-957[PMID:21869735 DOI:10.1097/TP.0b013e31822e6eda]
184 Sarin SK,Kedarisetty CK,Abbas Z,Amarapurkar D,Bihari C,Chan AC,Chawla YK,Dokmeci AK,Garg H,Ghazinyan H,Hamid S,Kim DJ,Komolmit P,Lata S,Lee GH,Lesmana LA,Mahtab M,Maiwall R,Moreau R,Ning Q,Pamecha V,Payawal DA,Rastogi A,Rahman S,Rela M,Saraya A,Samuel D,Saraswat V,Shah S,Shiha G,Sharma BC,Sharma MK,Sharma K,Butt AS,Tan SS,Vashishtha C,Wani ZA,Yuen MF,Yokosuka O.Acuteon-chronic liver failure:consensus recommendations of the Asian Pacific Association for the Study of the Liver(APASL)2014.Hepatol Int 2014;8:453-471[PMID:26202751 DOI:10.1007/s12072-014-9580-2]
185 Chen T,He Y,Liu X,Yan Z,Wang K,Liu H,Zhang S,Zhao Y.Nucleoside analogues improve the short-term and long-term prognosis of patients with hepatitis B virus-related acute-onchronic liver failure.Clin Exp Med 2012;12:159-164[PMID:22002708 DOI:10.1007/s10238-011-0160-7]
186 Liu XY,Wang HF,Hu JH,He WP,Wang HQ,Liu N.[The shortterm efficacy of nucleoside analogue on the treatment of acute-onchronic liver failure].Zhonghua Gan Zang Bing Za Zhi 2010;18:845-848[PMID:21138634 DOI:10.3760/cma.j.issn.1007-3418.2010.11.013]
187 Cui YL,Yan F,Wang YB,Song XQ,Liu L,Lei XZ,Zheng MH,Tang H,Feng P.Nucleoside analogue can improve the long-term prognosis of patients with hepatitis B virus infection-associated acute on chronic liver failure.Dig Dis Sci 2010;55:2373-2380[PMID:20512414 DOI:10.1007/s10620-010-1257-7]
188 Xie F,Yan L,Lu J,Zheng T,Shi C,Ying J,Shen R,Yang J.Effects of nucleoside analogue on patients with chronic hepatitis B-associated liver failure:meta-analysis.PLo S One 2013;8:e54773[PMID:23382964 DOI:10.1371/journal.pone.0054773]
189 Philips CA,Sarin SK.Potent antiviral therapy improves survival in acute on chronic liver failure due to hepatitis B virus reactivation.World J Gastroenterol 2014;20:16037-16052[PMID:25473156DOI:10.3748/wjg.v20.i43.16037]
190 Yu S,Jianqin H,Wei W,Jianrong H,Yida Y,Jifang S,Liang Y,Zhi C,Hongyu J.The efficacy and safety of nucleos(t)ide analogues in the treatment of HBV-related acute-on-chronic liver failure:a meta-analysis.Ann Hepatol 2013;12:364-372[PMID:23619252]
191 Huang K,Hu JH,Wang HF,He WP,Chen J,Duan XZ,Zhang AM,Liu XY.Survival and prognostic factors in hepatitis B virusrelated acute-on-chronic liver failure.World J Gastroenterol 2011;17:3448-3452[PMID:21876637 DOI:10.3748/wjg.v17.i29.3448]
192 Piscaglia AC,Arena V,Passalacqua S,Gasbarrini A.A case of granulocyte-colony stimulating factor/plasmapheresis-induced activation of granulocyte-colony stimulating factor-positive hepatic progenitors in acute-on-chronic liver failure.Hepatology 2015;62:649-652[PMID:25644621 DOI:10.1002/hep.27708]
193 Garg H,Sarin SK,Kumar M,Garg V,Sharma BC,Kumar A.Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure.Hepatology 2011;53:774-780[PMID:21294143 DOI:10 .1002/hep.24109]
194 Sun LJ,Yu JW,Zhao YH,Kang P,Li SC.Influential factors of prognosis in lamivudine treatment for patients with acute-onchronic hepatitis B liver failure.J Gastroenterol Hepatol 2010;25:583-590[PMID:19968744 DOI:10.1111/j.1440-1746.2009.06089.x]
195 Yang J,Chen G,Chen X,Zhang H,Jiang D,Yang G.Initial combination anti-viral therapy with lamivudine and adefovir dipivoxil decreases short-term fatality rate of hepatitis-B-virusrelated acute-on-chronic liver failure.Virol J 2015;12:97[PMID:26104153 DOI:10.1186/s12985-015-0323-3]
196 Liu F,Wang X,Wei F,Hu H,Zhang D,Hu P,Ren H.Efficacy and resistance in de novo combination lamivudine and adefovir dipivoxil therapy versus entecavir monotherapy for the treatmentnaive patients with chronic hepatitis B:a meta-analysis.Virol J2014;11:59[PMID:24673792 DOI:10.1186/1743-422X-11-59]
197 Sheng YJ,Liu JY,Tong SW,Hu HD,Zhang DZ,Hu P,Ren H.Lamivudine plus adefovir combination therapy versus entecavir monotherapy for lamivudine-resistant chronic hepatitis B:a systematic review and meta-analysis.Virol J 2011;8:393[PMID:21824397 DOI:10.1186/1743-422X-8-393]
198 Gustot T.Beneficial role of G-CSF in acute-on-chronic liver failure:effects on liver regeneration,inflammation/immunoparalysis or both?Liver Int 2014;34:484-486[PMID:24612170 DOI:10.1111/liv.12356]
199 Khanam A,Trehanpati N,Garg V,Kumar C,Garg H,Sharma BC,Sarin SK.Altered frequencies of dendritic cells and IFN-gammasecreting T cells with granulocyte colony-stimulating factor(G-CSF)therapy in acute-on-chronic liver failure.Liver Int 2014;34:505-513[PMID:24754047]
200 Garg V,Garg H,Khan A,Trehanpati N,Kumar A,Sharma BC,Sakhuja P,Sarin SK.Granulocyte colony-stimulating factor mobilizes CD34(+)cells and improves survival of patients with acute-on-chronic liver failure.Gastroenterology 2012;142:505 -512.e1[PMID:22119930 DOI:10.1053/j.gastro.2011.11.027]
201 Duan XZ,Liu FF,Tong JJ,Yang HZ,Chen J,Liu XY,Mao YL,Xin SJ,Hu JH.Granulocyte-colony stimulating factor therapy improves survival in patients with hepatitis B virus-associated acute-on-chronic liver failure.World J Gastroenterol 2013;19:1104-1110[PMID:23467275 DOI:10.3748/wjg.v19.i7.1104]
202 Shi M,Zhang Z,Xu R,Lin H,Fu J,Zou Z,Zhang A,Shi J,Chen L,Lv S,He W,Geng H,Jin L,Liu Z,Wang FS.Human mesenchymal stem cell transfusion is safe and improves liver function in acuteon-chronic liver failure patients.Stem Cells Transl Med 2012;1:725-731[PMID:23197664 DOI:10.5966/sctm.2012-0034]
203 Ma XR,Tang YL,Xuan M,Chang Z,Wang XY,Liang XH.Transplantation of autologous mesenchymal stem cells for endstage liver cirrhosis:a meta-analysis based on seven controlled trials.Gastroenterol Res Pract 2015;2015:908275[PMID:25861263 DOI:10.1155/2015/908275]
204 Sun K,Xie X,Xie J,Jiao S,Chen X,Zhao X,Wang X,Wei L.Cell-based therapy for acute and chronic liver failures:distinct diseases,different choices.Sci Rep 2014;4:6494[PMID:25263068 DOI:10.1038/srep06494]
205 Wang F,Zhou L,Ma X,Ma W,Wang C,Lu Y,Chen Y,An L,An W,Yang Y.Monitoring of intrasplenic hepatocyte transplantation for acute-on-chronic liver failure:a prospective five-year follow-up study.Transplant Proc 2014;46:192-198[PMID:24507050 DOI:10 .1016/j.transproceed.2013.10.042]
206 López-Velázquez JA,Chávez-Tapia NC,Ponciano-Rodríguez G,Sánchez-Valle V,Caldwell SH,Uribe M,Méndez-Sánchez N.Bilirubin alone as a biomarker for short-term mortality in acuteon-chronic liver failure:an important prognostic indicator.Ann Hepatol 2013;13:98-104[PMID:24378272]
207 Wu Y,You S,Zang H,Liu H,Mao Y,Mao P,Zhu B,Xu J,Xie G,Guo J,Li D,Xin S,Wan Z.Usefulness of serum thyroidstimulation hormone(TSH)as a prognostic indicator for acuteon-chronic liver failure.Ann Hepatol 2015;14:218-224[PMID:25671831]
208 Agiasotelli D,Alexopoulou A,Vasilieva L,Dourakis SP.Low free T3 levels are related to early mortality in patients with decompensated cirrhosis and acute-on chronic liver failure.J Hepatol 2014;61:1446-1447[PMID:25200906 DOI:10.1016/j.jhep.2014.06.042]
209 Maras JS,Maiwall R,Harsha HC,Das S,Hussain MS,Kumar C,Bihari C,Rastogi A,Kumar M,Trehanpati N,Sharma S,Pandey A,Sarin SK.Dysregulated iron homeostasis is strongly associated with multiorgan failure and early mortality in acute-on-chronic liver failure.Hepatology 2015;61:1306-1320[PMID:25475192DOI:10.1002/hep.27636]
210 Lin BY,Zhou L,Geng L,Zheng ZY,Jia JJ,Zhang J,Yao J,Zheng SS.High neutrophil-lymphocyte ratio indicates poor prognosis for acute-on-chronic liver failure after liver transplantation.World J Gastroenterol 2015;21:3317-3324[PMID:25805939 DOI:10 .3748/wjg.v21.i11.3317]
211 Liu H,Zhang H,Wan G,Sang Y,Chang Y,Wang X,Zeng H.Neutrophil-lymphocyte ratio:a novel predictor for short-term prognosis in acute-on-chronic hepatitis B liver failure.J Viral Hepat 2014;21:499-507[PMID:24750274 DOI:10.1111/jvh.12160]
212 Sargenti K,Prytz H,Nilsson E,Kalaitzakis E.Predictors of mortality among patients with compensated and decompensated liver cirrhosis:the role of bacterial infections and infection-related acute-on-chronic liver failure.Scand J Gastroenterol 2015;50:875-883[PMID:25697824 DOI:10.3109/00365521.2015.1017834]
213 Linderoth G,Jepsen P,Sch?nheyder HC,Johnsen SP,S?rensen HT.Short-term prognosis of community-acquired bacteremia in patients with liver cirrhosis or alcoholism:A population-based cohort study.Alcohol Clin Exp Res 2006;30:636-641[PMID:16573581]
